21/03/2025
SPONSORED ARTICLE
Elevating outcomes in robotic-assisted laparoscopic ventral hernia repair (VHR) enhances patient safety and recovery. Our study investigates the Arista™ Hemostatic Agent's impact on drain output and postoperative complications.
With 300,000+ VHR procedures annually in the U.S., minimizing complications like seromas and hematomas is critical. In a trial of 100 patients, we compared Arista™ with standard care.
Key findings:
- Arista™ group had an average drain output of 592.8 ml vs. 407.9 ml for control—a 39.6% increase (p = 0.01).
- No significant differences in blood loss, number of drains, operative time, or hospital stay.
- No seromas or hematomas recorded.
While Arista™ shows promise in increasing drain output, further research across diverse patient profiles and techniques is needed.
Discover more about our findings on our website: https://www.roboticsurgery.global/randomized-controlled-trial-of-the-outcomes-of-arista-hemostatic-agent-in-robotic-hernia-repair
Explore how Arista™ hemostatic agent impacts drain output and postoperative complications in hernia surgery.